Condition
Vulnerable Plaque
Total Trials
5
Recruiting
1
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
0.0%
-86.6% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
5Total
Not Applicable (4)
P 4 (1)
Trial Status
Not Yet Recruiting2
Terminated1
Active Not Recruiting1
Recruiting1
Clinical Trials (5)
Showing 5 of 5 trials
NCT07819643Phase 4Not Yet Recruiting
RESCUE: PCSK9 Inhibitors for Carotid Vulnerable Plaque Remodeling
NCT05333068Not ApplicableActive Not Recruiting
COMBINE-INTERVENE: COMBINEd Ischemia and Vulnerable Plaque Percutaneous INTERVENtion to Reduce Cardiovascular Events
NCT07107971Not ApplicableRecruiting
Drug-Eluting Balloon Treatment vs. Guideline-Directed Medical Therapy for the Treatment of Lipid-Rich Plaques
NCT06939374Not ApplicableNot Yet Recruiting
Intracoronary Cryotherapy Effect on Stabilization of Vulnerable Plaque in Patients With Stable Angina or ACS - A Traditional Feasibility Study
NCT02319733Not ApplicableTerminatedPrimary
Plaque Stabilization and Restoration by Bioresorbable Vascular Scaffold
Showing all 5 trials